- The PCL market is gaining momentum due to its excellent biodegradability, biocompatibility, and low melting point, which make it highly suitable for 3D printing, wound healing, orthopedic implants, and controlled drug release applications
- Surge in demand from the medical and healthcare sectors, particularly in the development of scaffolds and drug encapsulation, is significantly contributing to market growth
- North America dominated the polycaprolactone (PCL) market with the largest revenue share in 2024, driven by strong demand for biodegradable materials in medical and packaging industries, along with increasing investment in bioplastics research
- Asia-Pacific region is expected to witness the highest growth rate in the global polycaprolactone (PCL) market, driven by increasing demand for biodegradable materials, rising healthcare expenditure, and expanding applications of PCL in medical devices and packaging across countries such as China, Japan, and India
- The pellets segment accounted for the largest market revenue share in 2024, driven by its extensive use in manufacturing thermoplastic polyurethane (TPU), specialty compounds, and biodegradable plastics. Pellets are favored by manufacturers due to their ease of handling, consistent quality, and compatibility with standard polymer processing techniques such as extrusion and injection molding. The demand for PCL pellets is particularly high in the medical sector for producing long-term implantable devices
